A detailed history of Alps Advisors Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Alps Advisors Inc holds 25,756 shares of BSX stock, worth $2.18 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
25,756
Previous 29,586 12.95%
Holding current value
$2.18 Million
Previous $2.03 Million 2.12%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$67.33 - $77.71 $257,873 - $297,629
-3,830 Reduced 12.95%
25,756 $1.98 Million
Q1 2024

May 14, 2024

BUY
$57.6 - $68.62 $150,912 - $179,784
2,620 Added 9.72%
29,586 $2.03 Million
Q4 2023

Feb 14, 2024

SELL
$48.64 - $57.81 $85,606 - $101,745
-1,760 Reduced 6.13%
26,966 $1.56 Million
Q3 2023

Nov 14, 2023

SELL
$50.19 - $54.68 $34,631 - $37,729
-690 Reduced 2.35%
28,726 $1.52 Million
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $48,576 - $53,383
977 Added 3.44%
29,416 $1.59 Million
Q1 2023

May 10, 2023

SELL
$45.09 - $50.03 $42,114 - $46,728
-934 Reduced 3.18%
28,439 $1.42 Million
Q4 2022

Feb 14, 2023

SELL
$39.56 - $47.22 $205,237 - $244,977
-5,188 Reduced 15.01%
29,373 $1.36 Million
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $53,229 - $159,007
-1,450 Reduced 4.03%
34,561 $1.34 Million
Q2 2022

Aug 11, 2022

SELL
$35.24 - $47.1 $350,955 - $469,068
-9,959 Reduced 21.66%
36,011 $1.34 Million
Q1 2022

May 16, 2022

SELL
$40.9 - $45.1 $805,975 - $888,740
-19,706 Reduced 30.0%
45,970 $2.04 Million
Q4 2021

Feb 09, 2022

SELL
$38.07 - $44.87 $1.66 Million - $1.96 Million
-43,613 Reduced 39.91%
65,676 $2.79 Million
Q3 2021

Nov 15, 2021

SELL
$41.23 - $45.88 $14,966 - $16,654
-363 Reduced 0.33%
109,289 $4.74 Million
Q2 2021

Aug 11, 2021

SELL
$38.58 - $44.24 $57,754 - $66,227
-1,497 Reduced 1.35%
109,652 $4.69 Million
Q1 2021

May 07, 2021

SELL
$35.27 - $39.67 $396,187 - $445,613
-11,233 Reduced 9.18%
111,149 $4.3 Million
Q4 2020

Feb 03, 2021

BUY
$33.15 - $41.97 $1.39 Million - $1.77 Million
42,061 Added 52.37%
122,382 $4.4 Million
Q3 2020

Nov 04, 2020

BUY
$34.44 - $42.23 $265,222 - $325,213
7,701 Added 10.6%
80,321 $3.07 Million
Q2 2020

Aug 05, 2020

BUY
$30.19 - $39.11 $752,395 - $974,699
24,922 Added 52.25%
72,620 $2.55 Million
Q1 2020

May 06, 2020

BUY
$25.83 - $45.71 $580,064 - $1.03 Million
22,457 Added 88.97%
47,698 $1.56 Million
Q4 2019

Feb 07, 2020

BUY
$37.87 - $45.37 $10,187 - $12,204
269 Added 1.08%
25,241 $1.14 Million
Q3 2019

Nov 04, 2019

BUY
$40.31 - $43.45 $312,080 - $336,389
7,742 Added 44.93%
24,972 $1.02 Million
Q2 2019

Aug 07, 2019

BUY
$34.91 - $42.98 $65,421 - $80,544
1,874 Added 12.2%
17,230 $741,000
Q1 2019

May 01, 2019

BUY
$32.91 - $40.75 $43,770 - $54,197
1,330 Added 9.48%
15,356 $589,000
Q4 2018

Feb 04, 2019

SELL
$31.73 - $39.04 $62,222 - $76,557
-1,961 Reduced 12.27%
14,026 $496,000
Q3 2018

Oct 25, 2018

BUY
$32.83 - $38.63 $131,090 - $154,249
3,993 Added 33.29%
15,987 $615,000
Q2 2018

Aug 02, 2018

BUY
$26.84 - $34.32 $321,918 - $411,634
11,994 New
11,994 $392,000
Q2 2018

Jul 25, 2018

SELL
$26.84 - $34.32 $196,683 - $251,496
-7,328 Closed
0 $0
Q1 2018

May 01, 2018

BUY
$25.2 - $28.54 $184,665 - $209,141
7,328 New
7,328 $200,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $121B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.